Rhuph20 Injection
NDC Package 67062-0002-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Rhuph20 injection is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a injection delivery system. Marketed by Avid Bioservices Inc., this product is identified by NDC 67062-0002.

Identification & Billing

NDC Package Code
67062-0002-1
Package Description
10 mg in 1 BOTTLE
Product Code
67062-0002
11-Digit Billing Format
67062000201

Clinical Specifications

Proprietary Name
Rhuph20
Non-Proprietary Name
Rhuph20
Substance Name
Hyaluronidase Recombinant Human
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Active Ingredient(s)
HYALURONIDASE RECOMBINANT HUMAN 10 mg/10mg

Regulatory & Marketing

Labeler Name
Avid Bioservices Inc.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
06-22-2017
End Marketing Date
05-31-2028
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67062-0002-1 identifies a specific commercial package of 10 mg in 1 bottle of Rhuph20 (UNFINISHED drug), a bulk ingredient labeled by Avid Bioservices Inc.. This injection is formulated for use and contains hyaluronidase recombinant human as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Avid Bioservices Inc. on June 22, 2017.

How is this Avid Bioservices Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67062000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67062-0002-1
11-Digit CMS (5-4-2)
67062-0002-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.